It was reported through a research article identifying the mitraclip device which maybe be related to patient hemorrhage, tissue damage, atrial perforation, cardiogenic shock, cardiac embolism, stroke, cardiac tamponade, heart transplantation, ischemic stroke, myocardial infarction, renal failure, infections, heart failure, rehospitalization and difficult to grasp the leaflets.Details are listed in the article, titled percutaneous repair or medical treatment for secondary mitral regurgitation.No additional information was provided.
|
The device was not returned for analysis and a review of the lot history record and similar complaint review could not be performed as the part and lot information regarding the complaint device was not provided.The investigation was unable to determine a cause for the difficulty grasping and the patient effects of hemorrhage, tissue damage, atrial perforation, cardiogenic shock, embolism, cerebrovascular accident, cardiac tamponade, heart failure, transient ischemic attack, myocardial infarction, renal failure and infection.Hemorrhage, tissue damage, atrial perforation, cardiogenic shock, embolism, cerebrovascular accident, cardiac tamponade, heart failure, transient ischemic attack, myocardial infarction, renal failure and infection are listed in the instructions for use (ifu) as known possible complications associated with mitraclip procedures.The hospitalization, surgical procedure and additional therapy/non-surgical treatment were a result of case-specific circumstances as the patient remained hospitalized and underwent percutaneous mitral-valve repair in addition to receiving medical therapy.There is no indication of a product issue with respect to manufacture, design, or labeling.
|